Sorafenib Clinical Trials in Shanghai, Shanghai Municipality
2 recruitingShanghai, Shanghai Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
Acute Myeloid Leukemia (AML)Maintenance TherapyAllogeneic Hematopoietic Cell Transplantation (HCT)+3 more
The First Affiliated Hospital of Soochow University594 enrolled2 locationsNCT07463651
Recruiting
A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
Pancreatic Neuroendocrine NeoplasmSorafenibGefitinib
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine20 enrolled1 locationNCT06592989